Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.59
Price to sales ratio
2.28
Dividends per share
2.49
Dividend yield %
4.62

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
91
GILD
Gilead Sciences, Inc. - Common Stock
131.40 USD+1.21%-0.92%+4.95%+18.35%163.14 B USD
109
PFE
Pfizer, Inc. Common Stock
24.48 USD+1.20%+1.79%-6.88%-4.30%139.52 B USD
138
GSK
GSK plc American Depositary Shares
52.29 USD-0.95%-3.38%-1.66%+19.25%112.83 B USD
143
SNY
Sanofi - American Depositary Shares
44.00 USD+1.15%+1.92%-0.23%-9.39%107.31 B USD

Frequently asked questions about Bristol-Myers Squibb Company Common Stock

What is the Bristol-Myers Squibb Company Common Stock stock price today?

The current price of Bristol-Myers Squibb Company Common Stock (BMY) is 59.37. Over the past 24 hours, the stock has changed by +3.14%. Follow the BMY chart for real-time price dynamics.

What is the stock ticker of Bristol-Myers Squibb Company Common Stock?

Bristol-Myers Squibb Company Common Stock trades under the ticker BMY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bristol-Myers Squibb Company Common Stock stock going up?

BMY has changed by +2.73% over the last week, +4.16% over the last month, and +25.68% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Bristol-Myers Squibb Company Common Stock release financial reports?

Yes. You can track Bristol-Myers Squibb Company Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Bristol-Myers Squibb Company Common Stock net income for the last quarter?

Bristol-Myers Squibb Company Common Stock reported net income of 2.68 B for the last quarter. The previous quarter showed 1.09 B, which means net income changed by +146.27%.

How many employees does Bristol-Myers Squibb Company Common Stock have?

As of the latest available data, Bristol-Myers Squibb Company Common Stock has 32.5 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Bristol-Myers Squibb Company Common Stock EBITDA?

Bristol-Myers Squibb Company Common Stock EBITDA is 3.83 B, and its EBITDA margin is 33.36%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Bristol-Myers Squibb Company Common Stock stock?

You can buy Bristol-Myers Squibb Company Common Stock (BMY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bristol-Myers Squibb Company Common Stock stock?

Investing in Bristol-Myers Squibb Company Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BMY chart and related analysis on metatrader.com as part of your research.

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000.

News